Claritas Pharmaceuticals, Inc. Share Price
Stocks
CLAZF
CA1806342061
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
10:46:04 27/02/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 53.68L 38.35L 33.43L 31.53L 28.65L 37Cr 53.96L 3.77Cr 1.46Cr 19Cr 1.44Cr 1.41Cr 60Cr | P/E 2019 |
-0.74x | P/E 2020 | 0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 62.88L 44.92L 39.15L 36.93L 33.56L 43Cr 63.21L 4.42Cr 1.7Cr 22Cr 1.69Cr 1.65Cr 71Cr | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
99.74% | Yield 2019 * |
-
| Yield 2020 | - |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.4 |
| 10 years | 0 | | 15.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CEO | Chief Executive Officer | 76 | 21/06/2017 |
Victoria Rudman
DFI | Director of Finance/CFO | 58 | 29/06/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CHM | Chairman | 76 | 18/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/10/21 | Buy | 1,18,000 | 0.3332% | |||
| 11/10/21 | Buy | 1,52,500 | 0.4307% | |||
| 11/10/21 | Buy | 24,500 | 0.0692% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 37 | |
| +0.11% | +2.71% | +0.33% | +28.59% | 4.63TCr | |
| -1.12% | +1.78% | +40.07% | +27.26% | 4.39TCr | |
| -3.04% | -6.29% | +322.27% | +517.36% | 4.09TCr | |
| -0.74% | +1.25% | +2.32% | +67.94% | 3.99TCr | |
| -0.50% | +0.67% | +11.79% | +40.51% | 2.95TCr | |
| -0.46% | +4.22% | +21.99% | +124.21% | 1.71TCr | |
| -0.97% | -10.17% | - | - | 1.55TCr | |
| -0.57% | +8.12% | +22.15% | +38.93% | 1.52TCr | |
| -3.14% | +31.91% | -10.60% | - | 1.4TCr | |
| Average | -1.04% | +3.39% | +51.29% | +120.69% | 2.62TCr | |
| Weighted average by Cap. | -1.10% | +1.87% | +64.69% | +130.23% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.12Cr -1.52Cr -1.32Cr -1.25Cr -1.13Cr -145.39Cr -2.13Cr -15Cr -5.75Cr -74Cr -5.7Cr -5.57Cr -237.82Cr | 42.1L 30.07L 26.21L 24.73L 22.47L 29Cr 42.32L 2.96Cr 1.14Cr 15Cr 1.13Cr 1.11Cr 47Cr |
| Net Debt | 7L 5L 4L 4L 4L 4.83Cr 7L 49.43L 19.09L 2.45Cr 18.91L 18.49L 7.89Cr | 9L 7L 6L 5L 5L 6.31Cr 9L 64.6L 24.94L 3.21Cr 24.71L 24.16L 10Cr |
Employees
-
- Stock Market
- Stocks
- CLAZF Stock
Select your edition
All financial news and data tailored to specific country editions
